RBFOX1 also contributes to the aggressive malignant properties of glioma [15] and regulates the blood–tumor barrier to increase permeability in glioma, eventually resulting in a lower concentration of antineoplastic medication in brain tumors [16]. Here, RBFOX1 is linked to central nervous system cancer.